Background: Digoxin improves baroreflex function and reduces neurohumoral activation in severe heart failure, but it is uncertain how digoxin affects ventricular remodeling and progression to left ventricular dysfunction. In addition, the effect of digoxin in vitro β-adrenoceptor density and function, and contractile reserve in vivo is not well understood. Methods and Results: To study this, we compared digoxin with placebo treatment in rats with chronic volume overload induced by aortocaval fistula and in sham-operated control animals. Left ventricular end-diastolic cavity dimensions (LVDd) and wall thickness were measured weekly by in vivo transthoracic echocardiography, and left ventricular mass (LVM) and percent fractional shor...
This was a double-blind, placebo-controlled, crossover study designed to determine the influence of ...
Introduction: The main cause of cardiac transplantation is dilated cardiomyopathy (DCM), in which th...
Selective β 1-adrenoceptor antagonists are part of standard therapy to prolong survival in human hea...
Objectives.The present study examined left ventricular (LV) and myocyte contractile performance and ...
AbstractObjectives. This study evaluated the effect of digoxin on cardiac sympathetic activity in pa...
Background—Past studies have suggested that the adrenergic system becomes abnormally activated in ch...
Aims: To evaluate the effects of digoxin in patients with the newly described phenotype of heart fai...
Abstract Background The index of myocardial performance has prognostic power in patients with cardio...
BACKGROUND: Increased sympathetic activity contributes to the progression of heart failure. Adenosin...
<p><strong>BACKGROUND: </strong>Plasma iron excess can lead to iron accumulation in heart, kidney an...
Background: The doxorubicin (Dx) cardiotoxicity is manifested by a marked heart failure evolution. T...
BACKGROUND: Increased sympathetic activity contributes to the progression of heart failure. Adenosin...
Selective β -adrenoceptor antagonists are part of standard therapy to prolong survival in human hear...
AbstractDigoxin has been a controversial drug since its introduction >200 years ago. Although its ef...
This was a double-blind, placebo-controlled, crossover study designed to determine the influence of ...
This was a double-blind, placebo-controlled, crossover study designed to determine the influence of ...
Introduction: The main cause of cardiac transplantation is dilated cardiomyopathy (DCM), in which th...
Selective β 1-adrenoceptor antagonists are part of standard therapy to prolong survival in human hea...
Objectives.The present study examined left ventricular (LV) and myocyte contractile performance and ...
AbstractObjectives. This study evaluated the effect of digoxin on cardiac sympathetic activity in pa...
Background—Past studies have suggested that the adrenergic system becomes abnormally activated in ch...
Aims: To evaluate the effects of digoxin in patients with the newly described phenotype of heart fai...
Abstract Background The index of myocardial performance has prognostic power in patients with cardio...
BACKGROUND: Increased sympathetic activity contributes to the progression of heart failure. Adenosin...
<p><strong>BACKGROUND: </strong>Plasma iron excess can lead to iron accumulation in heart, kidney an...
Background: The doxorubicin (Dx) cardiotoxicity is manifested by a marked heart failure evolution. T...
BACKGROUND: Increased sympathetic activity contributes to the progression of heart failure. Adenosin...
Selective β -adrenoceptor antagonists are part of standard therapy to prolong survival in human hear...
AbstractDigoxin has been a controversial drug since its introduction >200 years ago. Although its ef...
This was a double-blind, placebo-controlled, crossover study designed to determine the influence of ...
This was a double-blind, placebo-controlled, crossover study designed to determine the influence of ...
Introduction: The main cause of cardiac transplantation is dilated cardiomyopathy (DCM), in which th...
Selective β 1-adrenoceptor antagonists are part of standard therapy to prolong survival in human hea...